# Alpha Biopharma

> Alpha Biopharma is a clinical-stage biopharmaceutical company founded in 2017 and headquartered in Shanghai, China, focused on the clinical development and commercialization of global innovative drugs in oncology and immunotherapy. Its lead product, Zorifertinib (Zorifer, formerly AZD-3759), is a next-generation EGFR TKI approved by China's NMPA in November 2024 for EGFR mutation positive advanced NSCLC with central nervous system metastases. The company is backed by Qiming Venture Partners.

Alpha Biopharma publishes a corporate marketing website only. As of 2026-07-20 it operates no public API, developer portal, SDKs, or machine-readable API specifications; package-registry and GitHub searches returned no first-party client libraries. This file is generated by the API Evangelist enrichment pipeline from the company profile; it is not published by Alpha Biopharma.

## Company

- [Alpha Biopharma](https://www.alphabiopharma.com/en/): Corporate homepage (English).
- [About Company](https://www.alphabiopharma.com/en/company/1.html): Company overview, capabilities, offices in Shanghai and Beijing.
- [Therapeutic Areas](https://www.alphabiopharma.com/en/ta/7.html): Oncology and immunotherapy focus areas.
- [Clinical Development Pipeline](https://www.alphabiopharma.com/en/productline/30.html): Product line and development pipeline.
- [EGFR-TKI Product](https://www.alphabiopharma.com/en/medicine1/32.html): Zorifertinib (Zorifer) product information.
- [Clinical Development](https://www.alphabiopharma.com/en/development/31.html): EGFR-TKI clinical development programs.
- [Publications](https://www.alphabiopharma.com/en/innovation/38.html): Scientific publications and innovation.
- [Investors](https://www.alphabiopharma.com/en/investment/27.html): Investor relations.
- [Corporate Social Responsibility](https://www.alphabiopharma.com/en/society/29.html): CSR programs.
- [Contact](https://www.alphabiopharma.com/en/contact/23.html): Corporate contact details.
- [Careers](https://www.alphabiopharma.com/en/vocation/20.html): Open roles.

## News

- [Corporate News](https://www.alphabiopharma.com/en/news/15.html): Company announcements.
- [Media Reports](https://www.alphabiopharma.com/en/news/36.html): Press coverage.

## API Evangelist

- [APIs.json profile](https://raw.githubusercontent.com/api-evangelist/alphabiopharma/refs/heads/main/apis.yml): Machine-readable company profile.
- [Domain security probe](https://raw.githubusercontent.com/api-evangelist/alphabiopharma/refs/heads/main/security/alphabiopharma-domain-security.yml): TLS, HSTS, DNSSEC, CAA, SPF and DMARC posture.
- [Well-known probe](https://raw.githubusercontent.com/api-evangelist/alphabiopharma/refs/heads/main/well-known/alphabiopharma-well-known.yml): Results of probing the standard discovery surface.
- [Package search](https://raw.githubusercontent.com/api-evangelist/alphabiopharma/refs/heads/main/packages/alphabiopharma-packages.yml): Registry and code-host search for first-party client libraries (none found).